Virtual Grand Opening of Virica’s Process Innovation Facility
Watch the grand opening of Virica’s Process Innovation Facility.
Virica Biotech Raises Series A Financing & Expands Operations to Support Clients’ Manufacturing of Viral Medicines
OTTAWA – October 4, 2021 – Virica Biotech Inc., a leading life science developer of solutions for scaling of viral medicines, announced today the first closing of its Series A financing. The round, led by Dynamk Capital, is expected to close with additional investors by the end of Q4-2021. The investment strengthens Virica’s already impressive growth trajectory, [...]
Virica Biotech: Enabling Vaccine Development to Fight Against COVID-19
March 14, 2020—As the world deals with COVID-19, now officially deemed a pandemic, many groups are racing against the clock to develop vaccines against the novel coronavirus. The development and manufacturing of effective vaccines is a laborious and challenging task for a variety of reasons. In the pandemic situation that we and our loved ones [...]
Virica’s Founder and CEO Dr. Jean-Simon Diallo Spoke with CBC’s All in a Day, Alan Neal
Virica’s Founder and CEO Dr. Jean-Simon Diallo spoke in an interview with CBC on All in a Day with Alan Neal on fighting the current COVID-19 pandemic by speeding up the process of mass-producing vaccines. Virica’s VSE technology which was spun out of the Ottawa Hospital Research Institute aims to overcome the manufacturing challenges that [...]
Virica’s Founder and CEO Dr. Jean-Simon Diallo interviewed by CTV Ottawa Morning
Virica’s Founder and CEO Dr. Jean-Simon Diallo discusses his latest virology research at the Ottawa Hospital Research Institute, which focuses on Covid-19 and is funded by the Ontario Government, with CTV Ottawa Morning. His team is using a biosensor that detects the interaction with the virus and its receptor which will allow them to rapidly [...]
Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization
Virica Biotech is proud to announce a critical $1 million collaborative project with Dr. Jean-Simon Diallo's Ottawa Hospital Research Institute lab that has been selected for grant financing by BioCanRx. The primary deliverable for this project is the generation of a set of regulatory assays and procedures forming a critical path that will enable the [...]
Virica Biotech to Participate in Two Accelerator Programs
Virica Biotech is excited to be participating in two accelerator programs: The Global US Market Expansion Accelerator – Global Soft Landing program and the Canadian Entrepreneurs in Life Sciences (CELS) program. These programs provide coaching and enable participating companies to form meaningful relationships with stakeholders, as well as establish a presence in the life sciences [...]
Virica presents at the BIO Investor Forum Digital (October 2020)
Hear from Ella Korets-Smith, Chief Business Officer & Co-Founder, as she presents the exciting programs that we are undertaking through our proprietary VSE technology to solve real world problems that face viral medicines.
Virica Biotech Participates in BARDA Lightning Talk
BARDA selected Virica Biotech to participate in a BARDA Lightning Talk on BARDA Industry Day. Virica was proud to participate and looks forward to connecting with attendees interested in its Viral Sensitizers. Visit the website. Hear from Jean-Simon Diallo, Scientific Founder and CEO, on how our VSE Technology is enhancing manufacturing of vaccines, including hopeful [...]